Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
192
394
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Income Statement
Earnings Waterfall
Diagnos Laboratorium Utama PT Tbk
|
Revenue
|
155.5B
IDR
|
|
Cost of Revenue
|
-88.2B
IDR
|
|
Gross Profit
|
67.3B
IDR
|
|
Operating Expenses
|
-73B
IDR
|
|
Operating Income
|
-5.7B
IDR
|
|
Other Expenses
|
965.1m
IDR
|
|
Net Income
|
-4.8B
IDR
|
Income Statement
Diagnos Laboratorium Utama PT Tbk
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue |
95 668
N/A
|
152 031
+59%
|
183 171
+20%
|
255 411
+39%
|
307 629
+20%
|
333 309
+8%
|
302 182
-9%
|
272 200
-10%
|
230 248
-15%
|
195 178
-15%
|
192 886
-1%
|
172 634
-10%
|
167 242
-3%
|
156 173
-7%
|
145 696
-7%
|
149 805
+3%
|
155 530
+4%
|
|
| Gross Profit | ||||||||||||||||||
| Cost of Revenue |
(56 531)
|
(82 763)
|
(96 461)
|
(130 553)
|
(148 471)
|
(164 062)
|
(151 681)
|
(136 331)
|
(122 904)
|
(105 470)
|
(97 881)
|
(92 405)
|
(92 112)
|
(89 315)
|
(85 899)
|
(86 768)
|
(88 233)
|
|
| Gross Profit |
39 137
N/A
|
69 268
+77%
|
86 710
+25%
|
124 859
+44%
|
159 158
+27%
|
169 247
+6%
|
150 500
-11%
|
135 868
-10%
|
107 344
-21%
|
89 708
-16%
|
95 006
+6%
|
80 229
-16%
|
75 129
-6%
|
66 857
-11%
|
59 797
-11%
|
63 037
+5%
|
67 297
+7%
|
|
| Operating Income | ||||||||||||||||||
| Operating Expenses |
(15 664)
|
(20 575)
|
(19 735)
|
(32 052)
|
(43 569)
|
(52 799)
|
(67 221)
|
(69 623)
|
(70 471)
|
(76 165)
|
(77 672)
|
(77 296)
|
(78 634)
|
(76 125)
|
(73 370)
|
(72 956)
|
(73 022)
|
|
| Selling, General & Administrative |
(11 880)
|
(17 696)
|
(18 323)
|
(29 730)
|
(43 596)
|
(51 016)
|
(66 143)
|
(66 737)
|
(65 528)
|
(70 103)
|
(72 298)
|
(72 075)
|
(73 151)
|
(70 974)
|
(65 503)
|
(64 152)
|
(64 701)
|
|
| Research & Development |
(1 106)
|
0
|
(593)
|
(683)
|
0
|
0
|
(274)
|
(390)
|
(543)
|
(714)
|
(586)
|
0
|
(510)
|
(364)
|
(249)
|
(484)
|
(337)
|
|
| Depreciation & Amortization |
(877)
|
(1 009)
|
(808)
|
(1 125)
|
(1 177)
|
(2 199)
|
(2 857)
|
(4 002)
|
(5 249)
|
(6 032)
|
(6 683)
|
(7 237)
|
(7 500)
|
(7 633)
|
(8 154)
|
(8 161)
|
(8 337)
|
|
| Other Operating Expenses |
(1 801)
|
(1 870)
|
(11)
|
(515)
|
1 204
|
416
|
2 052
|
1 506
|
848
|
685
|
1 895
|
2 015
|
2 528
|
2 847
|
535
|
(159)
|
352
|
|
| Operating Income |
23 473
N/A
|
48 692
+107%
|
66 975
+38%
|
92 807
+39%
|
115 590
+25%
|
116 448
+1%
|
83 279
-28%
|
66 245
-20%
|
36 873
-44%
|
13 543
-63%
|
17 333
+28%
|
2 933
-83%
|
(3 504)
N/A
|
(9 267)
-164%
|
(13 573)
-46%
|
(9 919)
+27%
|
(5 725)
+42%
|
|
| Pre-Tax Income | ||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
23 473
N/A
|
48 692
+107%
|
66 975
+38%
|
92 807
+39%
|
115 590
+25%
|
116 448
+1%
|
83 279
-28%
|
66 245
-20%
|
36 873
-44%
|
13 543
-63%
|
17 333
+28%
|
2 933
-83%
|
(3 504)
N/A
|
(9 267)
-164%
|
(13 573)
-46%
|
(9 919)
+27%
|
(5 725)
+42%
|
|
| Net Income | ||||||||||||||||||
| Tax Provision |
(5 998)
|
(11 669)
|
(14 289)
|
(19 889)
|
(25 012)
|
(27 535)
|
(18 975)
|
(15 336)
|
(8 233)
|
(1 055)
|
(4 669)
|
(2 134)
|
(1 997)
|
(878)
|
(83)
|
(53)
|
965
|
|
| Income from Continuing Operations |
17 475
|
37 023
|
52 687
|
72 918
|
90 578
|
88 913
|
64 304
|
50 909
|
28 639
|
12 488
|
12 665
|
799
|
(5 502)
|
(10 146)
|
(13 656)
|
(9 973)
|
(4 759)
|
|
| Net Income (Common) |
17 475
N/A
|
37 023
+112%
|
52 687
+42%
|
72 918
+38%
|
90 578
+24%
|
88 913
-2%
|
64 304
-28%
|
50 909
-21%
|
28 639
-44%
|
12 488
-56%
|
12 665
+1%
|
799
-94%
|
(5 502)
N/A
|
(10 146)
-84%
|
(13 656)
-35%
|
(9 973)
+27%
|
(4 759)
+52%
|
|
| EPS (Diluted) |
13.98
N/A
|
74.04
+430%
|
42.15
-43%
|
58.33
+38%
|
72.46
+24%
|
71.13
-2%
|
51.44
-28%
|
40.73
-21%
|
22.91
-44%
|
9.99
-56%
|
10.13
+1%
|
0.64
-94%
|
-4.4
N/A
|
-8.12
-85%
|
-10.92
-34%
|
-7.98
+27%
|
-3.81
+52%
|
|
You don't have any saved screeners yet
